Biotech developing gene therapies for orphan eye diseases.
Industry: Health Care
First Day Return: +23.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/10/2014 |
Offer Price | $12.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 4.2 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/26/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Alachua, FL, United States |
Founded | 1999 |
Employees at IPO | 17 |
Website www.agtc.com |